BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/14/2023 6:01:48 AM | Browse: 70 | Download: 147
 |
Received |
|
2023-09-13 18:28 |
|
Peer-Review Started |
|
2023-09-13 18:31 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-11-01 02:39 |
|
Revised |
|
2023-11-12 16:26 |
|
Second Decision |
|
2023-11-21 01:47 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2023-11-28 08:27 |
|
Articles in Press |
|
2023-11-28 08:27 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-12-11 06:01 |
|
Publish the Manuscript Online |
|
2023-12-14 06:01 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Pharmacology & Pharmacy |
| Manuscript Type |
Meta-Analysis |
| Article Title |
Vericiguat treatment of heart failure: A systematic review and meta-analysis
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Heng Yang, Chao Luo, Wan-Qi Lan and Yan-Hua Tang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Key Research and Development projects in Jiangxi |
20223BBG71010 |
| National Natural Science Foundation of China |
81960058 |
|
| Corresponding Author |
Yan-Hua Tang, PhD, Professor, Department of Cardiovascular Surgery, The Second Affiliated Hospital of Nanchang University, No.1 Minde Road, Donghu District, Nanchang City, Jiangxi Province, Nanchang 330008, Jiangxi Province, China. tyh6565@163.com |
| Key Words |
Vericiguat; Chronic heart failure; Randomized controlled trials; Meta analysis |
| Core Tip |
Heart failure is a major public health problem and a leading cause of mortality worldwide. Vericiguat may be a novel drug effective in slowing the progression of heart failure. We performed a meta-analysis and found that commonly used doses of Vericiguat resulted in a significant benefit in heart failure patients with reduced ejection fraction. Further studies are needed to confirm the long-term efficacy and safety of Vericiguat in heart failure. |
| Publish Date |
2023-12-14 06:01 |
| Citation |
Yang H, Luo C, Lan WQ, Tang YH. Vericiguat treatment of heart failure: A systematic review and meta-analysis. World J Clin Cases 2023; 11(35): 8330-8342 |
| URL |
https://www.wjgnet.com/2307-8960/full/v11/i35/8330.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v11.i35.8330 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
